2003, Number 2
<< Back Next >>
Gac Med Mex 2003; 139 (2)
Value of Gamma-Glutamyltransferase in Diagnosis of Metastatic Disease in Patients with Renal Cell Carcinoma.
Beltrán-Martínez RJ, Correa-Chacón AJ
Language: Spanish
References: 12
Page: 123-125
PDF size: 30.53 Kb.
ABSTRACT
Objective: Our objective was to determine the diagnostic value of gamma-glutamyltransferase (GGT) as a marker of metastatic disease in patients with renal cell carcinoma (CCR).
Material and methods: A study of diagnostic tests was carried out to determine the value of GGT as a marker of metastatic disease in patients with neoplasms of kidney cells (NKC). Eighteen patients from the Urology Service at the Specialties Hospital, National Medical Center La Raza were included in the period from March to December 1997 with diagnosis of NKC, independently of co-morbid states.
Results: In an independent and blinded form, studies of tumorlike extension were carried out on patients (bone gammagram, axial computered tomography of abdomen, thorax and skull) to determine whether localized NKC or metastatic NKC took place. We obtained sensitivity of 71.42%, specificity of 90.90%, positive predictive value 83.33%, and negative predictive value, 83.33%.
Conclusions: The study demonstrated that GGT values are high in a great percentage of patients with metastatic NKC, whereas in patients with localized CCR this enzyme practically is within normal ranges. Thus we are able to consider that GGT is useful as an indicator of metastasic disease in patients with CCR.
REFERENCES
1. Aranda-Michel J, Sherman KE. Tests of the liver: use and misuse. Gastroenterologist 1998;6(1):34-43.
2. Haningan MH, Frierson HF Jr. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissues. Histochem Cytochem 1996;44:1101-1108.
3. Yaagoubi M. Visvikis A. Khalid A. Siest G. Wellman M. 5-Azacytidine modulates gamma-glutamyltransferase and glutathione levels in two human prostatic adenocarcinoma cell lines. Biochem Molec Biol Int 1998;46(2):321-331.
4. Hanigan MH, Frierson HF Jr. Brown JE, Lovell MA, Taylor PT. Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Res 1994;54:286-290.
5. Bakerma, S. Gamma glutamyl transpeptidase (GGT). In: A.B.C.’s of interpretive laboratory data. Greenville, NC USA: Interpretive Laboratory Data, Inc., 1984. p. 209-210.
6. Turusov VS, Chemeris GY. Renal cell tumors induced in CBA male mice, by 1,2-dimethlyhydrazine. Toxicol Pathol 1992;20:570.
7. Arai K. Sumi SH, Toshida K, Komoda T. A precursor form of human kidney gamma-glutamyl transferase in normal & cancerous tissues and its possible post translational modification. Biochim Biophys Acta 1995;1263(1):33-38.
8. Karmowski A, Sobiech KA, Pawelec M, Palczynski B, Terpilowski L, Michalik T. Gamma-glutamyltransferase activity in the course of brachytherapy of the uterine cervix and corpus carcinoma. Ginekol Polska 1998;69(5):221-225.
9. Sandock DS, Seftel AD, Resnick MI. The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma. J. Urol 1997;157(3):798-799.
Sackket DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed Boston, MA, USA:Little, Brown and Company 1991.
Poikolainen K, Vartiainen E. Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol 1997;146(12):1019-1024.
Arndt Y, Brenner H, Rothenbacher D, Zschenderlein B, Fraisse E, Fliendner TM. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality. Int Arch Occup Environ Health 1998;71(6):405-412.